Long -term survival in stage IV esophageal adenocarcinoma with chemoradiation and serial endoscopic cryoablation

5Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Esophageal cancer has a poor overall prognosis and is frequently diagnosed at a late stage. Conventional treatment for metastatic esophageal cancer involves chemotherapy and radiation. Local disease control plays a significant role in improving survival. Endoscopic spray cryotherapy is a novel modality that involves freezing and thawing to produce local ablation of malignant tissue via ischemic mechanisms. Spray cryotherapy has been shown to be effective, particularly for early T-stage, superficial esophageal adenocarcinomas. We present the case of a 72-year-old-male with locally recurrent stage IV esophageal adenocarcinoma and long-term survival of 7 years to date, with concurrent chemoradiation and serial cryoablation. He remains asymptomatic and continues to undergo chemotherapy and sequential cryoablation. The findings highlight the long-term safety and efficacy of cryotherapy in combination with chemoradiation, and suggest that cryoablation may have an additive role in the treatment of advanced stage esophageal adenocarcinoma.

Cite

CITATION STYLE

APA

Spiritos, Z., Mekaroonkamol, P., El-Rayes, B. F., Force, S. D., Keilin, S. A., Cai, Q., & Willingham, F. F. (2017). Long -term survival in stage IV esophageal adenocarcinoma with chemoradiation and serial endoscopic cryoablation. Clinical Endoscopy, 50(5), 491–494. https://doi.org/10.5946/ce.2017.006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free